403 related articles for article (PubMed ID: 32462777)
1. Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation.
Vijayvargiya P; Camilleri M; Vijayvargiya P; Erwin P; Murad MH
Aliment Pharmacol Ther; 2020 Jul; 52(1):37-53. PubMed ID: 32462777
[TBL] [Abstract][Full Text] [Related]
2. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
Candy B; Jones L; Vickerstaff V; Larkin PJ; Stone P
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006332. PubMed ID: 29869799
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.
Nee J; Zakari M; Sugarman MA; Whelan J; Hirsch W; Sultan S; Ballou S; Iturrino J; Lembo A
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis.
Kistemaker KRJ; Sijani F; Brinkman DJ; de Graeff A; Burchell GL; Steegers MAH; van Zuylen L
Cancer Treat Rev; 2024 Apr; 125():102704. PubMed ID: 38452708
[TBL] [Abstract][Full Text] [Related]
5. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
Holder RM; Rhee D
Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
[TBL] [Abstract][Full Text] [Related]
6. Naloxegol: a review of its use in patients with opioid-induced constipation.
Garnock-Jones KP
Drugs; 2015 Mar; 75(4):419-25. PubMed ID: 25666542
[TBL] [Abstract][Full Text] [Related]
7. Peripherally acting μ-opioid antagonist for the treatment of opioid-induced constipation: Systematic review and meta-analysis.
Nishie K; Yamamoto S; Yamaga T; Horigome N; Hanaoka M
J Gastroenterol Hepatol; 2019 May; 34(5):818-829. PubMed ID: 30597600
[TBL] [Abstract][Full Text] [Related]
8. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients.
van Malderen K; Halawi H; Camilleri M
Neurogastroenterol Motil; 2018 May; 30(5):e13250. PubMed ID: 29119706
[TBL] [Abstract][Full Text] [Related]
9. Naloxegol for opioid-induced constipation in patients with noncancer pain.
Chey WD; Webster L; Sostek M; Lappalainen J; Barker PN; Tack J
N Engl J Med; 2014 Jun; 370(25):2387-96. PubMed ID: 24896818
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Peripherally Acting Mu-Opioid Receptor Antagonists for the Treatment of Opioid-Induced Constipation: A Bayesian Network Meta-analysis.
Ouyang R; Li Z; Huang S; Liu J; Huang J
Pain Med; 2020 Nov; 21(11):3224-3232. PubMed ID: 32488259
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
Mehta N; O'Connell K; Giambrone GP; Baqai A; Diwan S
Postgrad Med; 2016; 128(3):282-9. PubMed ID: 26839023
[TBL] [Abstract][Full Text] [Related]
12. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
Jones R; Prommer E; Backstedt D
Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis.
Ford AC; Brenner DM; Schoenfeld PS
Am J Gastroenterol; 2013 Oct; 108(10):1566-74; quiz 1575. PubMed ID: 23752879
[TBL] [Abstract][Full Text] [Related]
14. Peripherally-active mu-opioid receptor antagonists for constipation in critically ill patients receiving opioids: A case-series and a systematic review and meta-analysis of the literature.
Umbrello M; Venco R; Palandri C; Racagni M; Muttini S
Neurogastroenterol Motil; 2023 Dec; 35(12):e14694. PubMed ID: 37869768
[TBL] [Abstract][Full Text] [Related]
15. Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trials.
Hale M; Wild J; Reddy J; Yamada T; Arjona Ferreira JC
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):555-564. PubMed ID: 28576452
[TBL] [Abstract][Full Text] [Related]
16. Treating Opioid-Induced Constipation in Older Adults: New Options.
Sani H; Mahan RJ
Consult Pharm; 2015 Oct; 30(10):612-5. PubMed ID: 26450143
[TBL] [Abstract][Full Text] [Related]
17. Management of opioid-induced constipation in pregnancy: a concise review with emphasis on the PAMORAs.
Li Z; Pergolizzi JV; Huttner RP; Zampogna G; Breve F; Raffa RB
J Clin Pharm Ther; 2015 Dec; 40(6):615-9. PubMed ID: 26573866
[TBL] [Abstract][Full Text] [Related]
18. Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.
Streicher JM; Bilsky EJ
J Pharm Pract; 2018 Dec; 31(6):658-669. PubMed ID: 28946783
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Treatment of Opioid-Induced Constipation Is Effective but Choice of Endpoints Affects the Therapeutic Gain.
Nusrat S; Syed T; Saleem R; Clifton S; Bielefeldt K
Dig Dis Sci; 2019 Jan; 64(1):39-49. PubMed ID: 30284134
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation.
White WB; Kowey P; Diva U; Sostek M; Tummala R
J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):309-317. PubMed ID: 29504415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
